Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
SoftBank’s LY Corp, Bain Raise Kakaku.com Bid to ¥670 Billion, Intensifying Takeover Battle 
Meta Stock Jumps as AI Cloud Expansion Challenges AWS, Microsoft, and Google 
Trump Reports $1.4 Billion in Crypto Income as Digital Assets Become Top Wealth Source 
Michael Burry Shorts Tesla at $416 as AI and Semiconductor Bearish Bets Expand 
Super Micro Employees Detained in Taiwan AI Server Export Investigation 
NASA Resumes Cygnus XL Cargo Docking with Space Station After Software Fix 
Asian Currencies Stay Under Pressure as Dollar Holds Near 13-Month High Ahead of U.S. Jobs Report 
US Stock Futures Hold Steady Ahead of June Jobs Report as Fed Rate Outlook Remains in Focus 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
EU Chip Industry Faces Growing Risks From China Export Controls and U.S. Technology Dependence: Report 
India Manufacturing PMI Slows in June as Demand Weakens Despite Lower Cost Pressures 
Samsung to Invest $90 Billion in South Korea to Expand AI Chip, Display, and Battery Production 
U.S. Stocks End Q2 Higher as Strong Jobs Data and AI Rally Lift Wall Street 
Chip Stocks Rally as Samsung and SK Hynix’s $1.3 Trillion Investment Plan Boosts AI Optimism 
Northern Star Appoints New CEO as Activist Elliott Pushes for Leadership Overhaul 
Gold Price Drops to Eight-Month Low as Fed Rate Hike Bets Weigh on Bullion. Source: Photo by Michael Steinberg via Pexels 
Kyoto University researchers have regenerated neural stem cells in an adult mouse and improved its cognitive function through its method, dubbed "iPaD."
The test results were equivalent to turning a 60-year-old-human's neural stem cells into those of a teenager.
However, there are challenges in applying the procedure to humans because the mouse’s genetic engineering involved using a virus to inject the genes into the brain.
The research team’s leader, visiting professor Ryoichiro Kageyama, said they would continue to see if the procedure can be applied to humans.
The team will now test its iPaD method on marmosets to determine if its applicability to primates.
The ability to multiply embryonic neural stem cells to increase the number of nerve cells weakens with age. That, in turn, results in reduced cognitive function.
The iPaD method maximizes the activation of the neural stem cells by combining the infant mice’s most active genes with a restraining function of the adult mice’s most active genes.
The engineered neural stem cells in an adult mouse became more active with the neural stem cells continuing to multiply for about three months.
|Consequently, the adult mouse improved its cognitive function with the increase in neural stem cell multiplication.
